<bill session="115" type="h" number="1703" updated="2017-06-22T18:19:02Z">
  <state datetime="2017-03-23">REFERRED</state>
  <status>
    <introduced datetime="2017-03-23"/>
  </status>
  <introduced datetime="2017-03-23"/>
  <titles>
    <title type="short" as="introduced">Medical Product Communications Act of 2017</title>
    <title type="short" as="introduced">Medical Product Communications Act of 2017</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act with respect to determining the intended use of drugs and devices.</title>
    <title type="display">Medical Product Communications Act of 2017</title>
  </titles>
  <sponsor bioguide_id="G000568"/>
  <cosponsors>
    <cosponsor bioguide_id="B001257" joined="2017-06-02"/>
  </cosponsors>
  <actions>
    <action datetime="2017-03-23">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-03-23" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2017-03-24">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Scientific communication"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
